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Content summary: 
 This study investigates the agreement between IQ scores of short form and full length 
assessments in patients at risk for neurodevelopmental disorders
 A bias was found between full length IQs and estimated short-form IQs at the tails of 
the distribution
 A correction formula was provided to improve the agreement between short form and 
full length IQ scores 
 This is of particular interest when short form IQ scores are assessed in populations with 
an increased proportion of individuals with low IQ scores. 



































































Background: Short forms of IQ (S-IQ) assessments are time-efficient and highly predictive of 
the full IQ (F-IQ) in healthy individuals. To investigate the validity of S-IQs for patients with 
neurodevelopmental impairments, this study tested a well-established S-IQ version in patients 
with congenital heart disease (CHD). 
Methods: The Wechsler Intelligence Scale for Children, Fourth Edition was applied in 107 
children with complex CHD aged 9 to 11 years. F-IQ and a well-established S-IQ version were 
calculated for each patient. The agreement between S-IQ and F-IQ was investigated across the 
whole spectrum of IQ scores. Finally, we tested a method to adjust IQs to resolve potential bias 
and validated this method in an independent sample of 55 CHD patients. 
Results: S-IQ and F-IQ correlated strongly. Nevertheless, the size of the bias correlated with 
the true IQ, indicating larger error at the tails of the distribution. Estimating a corrected IQ by 
adjusting the S-IQ with correction parameters substantially improved agreement. 
Conclusion: We here report that substantial bias may underestimate low IQ scores and 
overestimate high ones. This bias should be considered when at-risk populations are assessed 
with S-IQs. Importantly, the bias can be minimized by using a correction formula.



































































Many neurodevelopmental disorders are characterized by deficits in general intellectual 
abilities, reflected in lower intelligence quotients (IQs) than those of typically developing 
peers. For example, the mean IQ of preterm cohorts has been reported to lie about 10 IQ points 
below that of typically developing children (see Allotey et al. (1) for a meta-analysis). Children 
with congenital heart disease (CHD) after cardiopulmonary bypass (CPB) surgery have 
comparable IQ deficits (2–4). Low IQ scores, particularly those below internationally 
recognized cut-offs defining learning and intellectual disability, are associated with a higher 
need for therapeutic interventions and educational action (5,6). Consequently, IQ assessments 
in children at risk for neurodevelopmental disorders can guide long-term care and ensure the 
timely initiation of support (7,8).
In research settings, IQ assessment often complements the assessment of other 
neurodevelopmental domains, such as executive functions (9). A common practice in such 
settings is to administer only a subset of the tests used for full-scale IQ (F-IQ) assessment to 
avoid lengthy protocols, because these may reduce performance due to fatigue or loss of 
motivation in patients (10,11). Regression equation models have been developed to estimate 
IQ from various subsets of tests (11,12). These short IQ (S-IQ) assessments have been proven 
to accurately predict the F-IQ in large samples of typically developing children and adolescents 
(10,11) and in patients with neurological disorders (13). Moreover, most children with 
intellectual disabilities were identified correctly when S-IQ assessments were applied (14). 
Importantly, the administration of S-IQ assessments has been shown to reduce testing time by 
more than 50% compared to the administration of the full test (15).
So far, research on the appropriateness of S-IQ assessments in neurodevelopmental disorders 
has been limited. Several studies have tested various S-IQ versions in patients at risk for 
neurodevelopmental deficits, and their findings can guide the optimal selection of subtests for 


































































specific clinical populations (16–18). However, these studies have not examined whether S-IQ 
versions accurately measure IQ across the whole spectrum of IQ scores. In fact, there is 
evidence for a large bias in S-IQ scores outside the normal IQ range in healthy adults (19). This 
bias may be particularly pronounced in neurodevelopmental disorders due to the distribution 
shift towards lower IQ scores (7).
Consequently, this study aimed to comprehensively investigate the appropriateness of S-IQ 
assessment in a group of patients at risk for neurodevelopmental disorders, CHD patients. 
Specifically, we tested whether S-IQ assessments adequately estimate IQ across the whole 
spectrum of scores when IQ was assessed with the Wechsler Intelligence Scale for Children 4th 
Edition (WISC-IV). Further, we present a statistical approach to minimizing potential bias 
between S-IQ and F-IQ and validated this in an independent cohort of CHD patients.




































































Patients were recruited from the Research and Child Health Outcome (REACHOUT) cohort, 
which consists of 211 children who underwent CPB surgery at the University Children’s 
Hospital Zurich, Switzerland between 2004 and 2009. This prospective cohort study included 
5 assessments: Before surgery and at 1, 4, 6, and 10 years of age. The current study uses the 
data from the 10-year neurodevelopmental assessment (see Figure 1). Patients with a genetic 
or dysmorphic syndrome, CPB before study enrolment, or age above 6 years at first surgery 
were excluded from the 10-year assessment. Of 190 eligible patients, 136 agreed to participate. 
Twenty-eight patients did not complete all subtests of the WISC-IV required to calculate the 
S-IQ used in this study and were therefore excluded. In total, data of 107 patients was analyzed 
for the current study. To enable correction parameters to be developed, the total sample (S1) 
was divided into 2 subsamples (S1b, S1a) by random sampling.
The reproducibility of our findings was confirmed in an independent sample of patients with 
CHD (S2): We used the IQ data of 55 patients with CHD from a retrospective cohort study on 
CHD conducted at the University Children’s Hospital Zurich. These participants underwent 
CPB between 1995 and 1998 and were aged 11 to 16 years at the time of the study (for further 
details see Schaefer et al. (4)). 
The Ethical Committee of the Canton of Zurich, Switzerland approved both cohort studies. 
Written informed consent was obtained prior to the study participation from parents and from 
participants older than 11 years.
2.2. Outcome measures 
IQ was assessed by well-trained professionals using the full-length German version of the 
WISC-IV (20). Information on the heart defect was collected from medical records. Socio-


































































economic status (SES) was estimated by rating maternal education and paternal occupation on 
a 6-point scale ranging from 2 to 12 (21).
F-IQ was calculated according to the instructions provided in the manual of the WISC-IV and 
adjusted for age. The S-IQ was estimated according to a regression equation method described 
by Waldmann (11). We selected a subtest combination that retains the conceptual structure of 
the WISC-IV to preserve construct validity. This includes one subtest from each of the 4 
indices: working memory, processing speed, reasoning, and verbal comprehension. One-per-
index-subtest combinations are often used in research to estimate IQ (22–24). Of these subtest 
combinations, we chose the equation with the highest reliability according to Waldmann (11) 
(R2 = 0.911; subtests: letter–number sequencing, symbol search, matrices, vocabulary). 
2.3. Statistical analyses 
Sample characteristics—sex, age, SES, and type of heart defect (cyanotic, acyanotic)—are 
reported for both the full sample (S1) and the 2 subsamples (S1a, S1b) and the validation sample 
(S2). Two-sided Welch’s t-test allowing for unequal variance and a two-sampled chi-squared 
test were used to investigate the comparability of the 2 subsamples (S1a and S1b) and the full 
(S1) and validation samples (S2). 
2.3.1. Correlation and agreement between S-IQ and F-IQ 
The correlation between the F-IQ and the S-IQ was examined using Spearman’s correlation. 
We conducted 2 types of analyses to investigate the agreement between the F-IQ score and the 
S-IQ. First, we examined the overall agreement: We tested for a significant mean difference 
between the S-IQ and the F-IQ (i.e. the mean bias) by using a paired two-sided t-test. Further, 
the proportion of participants with a bias ≤ 5 IQ-points (within 95% CI) was calculated. Second, 
we analyzed whether the bias between the two IQ measurements (F-IQ, S-IQ) depends on the 


































































IQ itself (i.e., whether the bias is equal across the whole IQ spectrum). Thus, we correlated the 
bias with the estimated true IQ using Spearman’s correlation (25). The bias was defined as the 
absolute difference between the F-IQ and the S-IQ, and the true IQ was estimated from the 
mean of the S-IQ and F-IQ because using either value separately would cause a statistical 
artifact (26).
Agreement was further tested by dichotomizing the data above a clinically relevant cut-off into 
normal (IQ ≥ 85) or below into abnormal IQ (IQ < 85). In order to test for agreement, a two-
sampled chi-squared test was conducted using IQ type (F-IQ, S-IQ) as predictor and IQ score 
(normal, abnormal) as outcome. Further, the proportion of patients who fell into the same 
category for the S-IQ and the F-IQ was calculated.
2.3.2.Correction method for S-IQ. 
To minimize the bias between the F-IQ and the S-IQ, we applied a statistical method to estimate 
a corrected IQ. Therefore, the full sample (S1) was split into 2 subsamples by means of random 
sampling (S1b, S1a). We calculated a linear regression model for the subsample S1a, using S-IQ 
as predictor and F-IQ as outcome (F-IQ = β0 + β1* S-IQ). The intercept (β0) and slope (β1) were 
then used in the correction model to predict the corrected IQ of the subsample S1b: 
Corrected IQ1b = β01a + β11a * S-IQ1b
Two measures for quantifying the agreement with the F-IQ were calculated: the root mean 
square error (RMSE) and the mean absolute error (MAE). These were calculated for both the 
S-IQ and the corrected IQ and were then compared. A lower RMSE and MAE in the corrected 
IQ than in the S-IQ was interpreted as improvement of agreement.


































































2.3.3. Validation of the correction method.
Finally, we validated the correction method in another independent sample of CHD patients. 
We estimated a corrected IQ in the validation sample (S2) by implementing our correction 
parameters obtained from the subsample S1a (β0, β1) to the S-IQ of the validation sample (S2). 
All the statistical analyses were performed using the R computing environment, version 3.5.3 
(27,28). All analyses were performed with an α-level of 0.05. 




































































Table 1 provides sample characteristics of the full sample (S1), the 2 subsamples (S1a, S1b), and 
the validation sample (S2). Evidence for differences between the full and validation samples 
were found for age (t(55.7) = 16.60, P < 0.001, CI-95: from 3.03 to 3.86), and sex (χ 2(1) = 
6.21, P = 0.01). There was no difference for the type of heart defect (cyanotic and acyanotic; 
χ 2(1) = 1.64, P = 0.2) and only weak evidence for a difference in SES (t(92.9) = 1.88, P = 
0.06, CI-95: from -0.04 to 1.47). The 2 subsamples (S1a, S1b) did not differ in patient 
characteristics (see Table 1).
Table 2 provides F-IQ, S-IQ, and the mean difference between the F-IQ and the S-IQ (i.e., 
bias) for the full sample, the 2 subsamples and the validation sample. There was strong 
evidence of a difference in the mean F-IQ between the full sample S1 and the validation sample 
S2 (t(90.6) = 3.09, P = 0.003, CI-95: from 2.88 to 13.23). There was no evidence of a difference 
in mean F-IQ between the 2 subsamples (S1a, S1b: t(104.0) = 0.22, P = 0.8, CI-95: from -4.60 
to 5.76).
3.2. Correlation and agreement between S-IQ and F-IQ 
The analysis revealed a very strong correlation between the S-IQ and the F-IQ in the full sample 
(S1: r = 0.95, P < 0.001, Figure 2A). A two-sided paired t-test provided no evidence of a 
difference between S-IQ and F-IQ (S1: t(106) = 1.50, P = 0.1, CI-95: from -0.28 to 2.04). The 
mean difference between S-IQ and F-IQ (i.e., mean bias) in the full sample was 0.9 IQ point 
(Table 2). Furthermore, 81% of all participants had a bias ≤ 5 IQ points.
When considering IQ scores across the whole IQ spectrum, our findings revealed a very strong 
correlation between bias and the true IQ score (S1: r = -0.62, P < 0.001). A Bland-Altman plot 


































































of difference (Figure 2B) illustrates the underestimation of S-IQ for true IQ scores below the 
mean and the overestimation of S-IQ for true IQ scores above the mean. 
Categorizing S-IQ and F-IQ scores as normal (IQ ≥ 85) or abnormal (IQ < 85) revealed no 
evidence for a difference in the distribution between the categories in the full sample (S1: χ 2(1) 
= 0.65, P = 0.4). The proportion of patients of the full sample (S1) who fell into the same 
category for the S-IQ and the F-IQ was 93%.
3.3. Correction method for S-IQ 
The correction of the S-IQ of subsample S1b with the parameters (β0, β1) from the subsample 
S1a resulted in a mean corrected IQ of 95.7 (SD = 12.2, Table 2). The correlation between the 
F-IQ and the corrected IQ remained strong (r = 0.94, P < 0.001, Figure 3B; for comparison: 
correlation between F-IQ and uncorrected S-IQ: Figure 3A). Both RMSE (RMSES-IQ = 6.0; 
RMSEcorrected IQ = 4.1) and MAE (MAES-IQ = 4.5; MAEcorrected IQ = 3.3) were lower in the 
corrected IQ than in the S-IQ. This is evidence for successful correction of the bias using the 
correction formula provided in this study. 
To test the stability of the correction method, correction parameters (β0, β1) were also extracted 
from subsample S1b and applied to subsample S1a. The results were identical (see Supplemental 
Figure S1 for details). Correction parameters for all one-per-index-subtest combinations with 
an r > 0.9, (11) and for further combinations consisting of 2 to 6 subtests are listed in the 
Supplemental Table S2a and Figure S2b.
3.3.1. Validation of the correction method


































































The correction method was applied in a validation sample (S2) to further confirm its stability. 
Adjusting the S-IQ of the validation sample (S2) with the correction parameters (β0, β1) from 
the subsample (S1a) resulted in a mean corrected IQ of 104.9 (SD = 15.9, Table 2). The 
correlation between the F-IQ and the corrected IQ remained strong (r = 0.93, P < 0.001, 
Supplemental Figure S3). Both RMSEs (RMSES-IQ = 7.8; RMSEcorrected IQ = 4.6) and MAE 
(MAES-IQ = 6.3; MAEcorrected IQ = 3.4) were lower in the corrected IQ than in the S-IQ. This is 
evidence for successful correction of the bias in the validation sample.



































































In this study, we investigated whether short forms of IQ assessments (S-IQ) accurately estimate 
IQ scores in patients at risk for neurodevelopmental disorders. Our results indicate that while 
the correlation between the full-length IQ assessment (F-IQ) and S-IQ is high overall, IQ scores 
at the tails of the distribution are not accurately measured when using S-IQ assessments. Using 
our correction method, we were able to considerably reduce this bias.
In this analysis of children and adolescents with CHD, a population with frequent 
neurodevelopmental impairments, we calculated F-IQ scores from the full WISC-IV and S-IQ 
scores from a well-established 4-subtest version (11). First, we demonstrated a strong 
correlation between the S-IQ and the F-IQ scores. These findings are in line with previous 
studies on both healthy participants (10,11) and patients with neurological disorders (13,17). 
On examining the agreement between these two IQ measures, we observed a substantial 
variation in bias across the spectrum of IQ: S-IQ scores were underestimated in the lower 
spectrum of IQ and overestimated in the higher spectrum. This bias was replicated in various 
other subtest combinations (see Supplemental Table S2a and Figure S2b) and in an independent 
sample of CHD patients. A previous study in healthy adults that used other estimates of the 
Wechsler adult intelligence scale, 3rd edition, also reported larger bias at the tails of the 
distribution (19).
Time-efficient assessments of IQ by means of S-IQ methods are particularly valuable in 
research settings because IQ is often not the primary outcome of interest but serves merely as 
a covariate or patient characteristic to allow inferences to be drawn about potential selection 
bias and generalizability from the assessed cohort (29). Using short forms allows more time 
for the detailed assessment of developmental domains of interest, such as executive function 
(4,9) and memory performance (30). However, the usefulness of S-IQs has long been a matter 
of debate (31,32). In particular, concerns have been raised whether the construct validity 


































































assessed in a sample with a full-length assessment holds true when only a subsample of tests 
is applied (11,32). For this reason, we aimed to retain the best construct validity possible by 
using a one-subtest-per-index short form. This approach has frequently been used in previous 
studies (e.g. (22–24)). Furthermore, it has been debated whether S-IQ scores are valid in 
samples whose IQ distributions differ from those of the general population, for example in 
patients with population-specific cognitive deficits. Indeed, several studies have reported 
considerable mean IQ differences between S-IQ and F-IQ versions in cohorts of patients with 
epilepsy (17), traumatic brain injury (16), neurologic disorders (13), and borderline intellectual 
disabilities (18). However, these studies only investigated overall mean differences between 
the S-IQ and the F-IQ, not the changing size and direction of bias across the whole spectrum 
of IQ scores. Our finding that bias is largely restricted to the tails of the distribution suggests 
that the significant mean differences observed in those studies likely occurred due to large 
biases in low IQ scores. 
Importantly, the bias observed between the mean S-IQs and F-IQs of a population only 
provides very limited information on the agreement between the 2 measures because it does 
not reflect the spectrum of scores. The concept of agreement has been discussed extensively in 
the past. Unfortunately, there is confusion about appropriate concepts to test the agreement 
between 2 measurements, and this can lead to misinterpretation of results (33). Appropriate 
methods to investigate agreement consider the degree of bias across the whole spectrum of 
scores and therefore provide substantial information about the quality of a measurement (25). 
Therefore, this study examined bias across a whole spectrum of IQ scores by correlating the 
bias with the estimated true IQ, as suggested by Altman and Bland (25).
The fact that the bias occurs predominantly at the tails of the distribution may reflect a 
statistical phenomenon, called regression to the mean, which causes one measurement to be 
closer to the population mean than another measurement of the same entity. This is especially 


































































apparent for values outside the normal range (34). Regression to the mean has previously been 
discussed as a problem affecting the interpretation of IQ scores (35–37). In particular, F-IQ 
scores outside the normal range tend to be closer to the mean than the corresponding S-IQ 
scores, since sporadic extreme subtest scores are weighted less in the F-IQ. Our findings show 
that it is particularly important to consider the distribution of the data when S-IQ scores of 
populations at risk for neurodevelopmental impairments are used in statistical analyses. 
To overcome the bias between F-IQ and S-IQ measures, we tested a correction method to 
resolve this problem. Correction parameters were obtained from one subsample and were 
applied to the other subsample to estimate a corrected IQ. We observed an improved agreement 
between the 2 measurements: The RMSE of the S-IQ was as high as 6 before the correction, 
indicating low agreement (11). The RMSE of the corrected IQ was substantially reduced 
(RMSE = 4.1), reflecting a considerable improvement in agreement. These findings underline 
that correcting S-IQ scores may well improve the validity of an estimate, especially when its 
distribution differs from the normative sample.
The correction formula proved useful both when subdividing the full sample into 2 random 
subsamples and when correcting the S-IQ of an independent validation sample of CHD patients 
(S2). Indeed, very similar improvements of IQ estimations were found in the validation sample 
that was different in regard to age, SES, and sex. The mean F-IQ of the validation sample and 
its distribution differed strongly from the original full sample (S1). In fact, the mean IQ of the 
validation sample was above average, and its distribution was left-skewed, in all likelihood due 
to selection bias (4). Nevertheless, the correction formula also worked in this very different 
sample of patients with CHD. This implies that the correction formula we present here may 
also reduce bias in other samples with abnormal distributions of IQ, irrespective of the direction 
of the skewness. This may be of particular interest for the correction of bias in typically 


































































developing control groups, as sampling bias is a well-known problem with high-functioning 
individuals (38). 
If IQ estimates serve to describe the proportion of individuals with clinically relevant IQ 
deficits, S-IQ scores may be categorized into normal (IQ ≥ 85) and abnormal IQ (IQ < 85). Our 
findings reveal that a high proportion of participants were categorized correctly with the S-IQ. 
These findings are in line with a study by Murray and colleagues (14), who used a cut-off score 
of 70 and successfully identified children with intellectual disabilities using an S-IQ estimation. 
This method is easy to apply when concerns about bias are present. However, categorizing data 
results in a loss of valuable information (39). Therefore, it is important to consider why the IQ 
has been measured and decide whether using categories only is appropriate. 
Taken together, using S-IQs and the presented correction formula may be useful in research 
settings to provide an appropriate estimation of general intellectual abilities, especially when 
IQ serves as a secondary outcome. In clinical settings, the full length assessment of IQ is, 
however, preferable as only this provides a detailed assessment of the global IQ and the 
respective indices. This is required to identify deficits in specific cognitive domains and to 
initiate appropriate interventions.
4.1. Limitations
Our study has several limitations worth mentioning. We investigated a cohort of patients with 
CHD as one example of populations at risk for neurodevelopmental impairments. Therefore, 
our findings cannot directly be transferred to other at-risk populations. Other studies should 
investigate clinical populations with a higher proportion of individuals with very low IQ (e.g. 
severe intellectual disabilities) in order to confirm the validity of the correction formula. Also, 
future studies should validate our findings in populations with different profiles of cognitive 
impairment . Nevertheless, the cognitive profile of children born very preterm is akin to that of 


































































patients with CHD (40), so we propose that the correction formula presented here could also 
be applied to correct the S-IQ scores of preterm-born children.
We did not have a control sample assessed with the full WISC-IV. Therefore, we could not 
compare the correlation and agreement of F-IQ with S-IQ between typically developing 
children and adolescents and those with CHD. However, a study by Spinks and colleagues (19) 
in healthy adults has also reported a higher proportion of large bias (> 5 IQ points) at the tails 
of the distribution than within the normal range. This finding indicates that the bias in the outer 
spectrum may also occur in cohorts of healthy individuals. The proportion of individuals with 
IQ scores below 85 is rather low in typically developing cohorts, though, so this may have less 
bearing than in at-risk populations. 
This study only investigated estimates of IQ by means of equation models but did not consider 
other methods (e.g. Wechsler abbreviated scale for intelligence 2nd Edition (WASI-II), 
Wechsler 2011). This was mainly because the equation models published by Waldmann (11) 
are frequently used in research on German-speaking populations with various clinical 
characteristics (e.g. (22–24)). Further, we only investigated a variety of 4-subtest versions 
designed to minimize testing time while retaining the conceptual structure of the WISC-IV. 
Thus, we cannot draw any conclusion regarding the agreement and potential correction 
methods in S-IQ obtained from other estimates. 
Our analyses on S-IQ were done with data of patients who conducted the full length WISC-IV 
assessment. Applying a short form version requires considerably less time (15), which may 
lead to less fatigue and better motivation (13), resulting in a better outcome. This has to be 
considered when short forms and the presented correction formula are used. However, the short 
form estimates by Waldmann (11) were also developed from data of the full length assessment. 
Our analyses are, therefore, in line with the original work of Waldmann.



































































S-IQs measured in a sample of children with CHD with a well-established 4-subtest version 
revealed a lack of agreement with F-IQs at the tails of the distribution, namely in low and high 
performers of the WISC-IV. This warrants particular consideration when investigating 
populations whose IQ scores differ from those of the general population. Bias between S-IQ 
and F-IQ scores can be diminished either by dichotomizing the data into scores above or below 
85 or by using a correction formula presented in this study.
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Figure Legends 
Figure 1: Flow diagram of participant selection for sample S1. y FU = year follow up
Figure 2: A) Correlation of S-IQ and F-IQ. B) Correlation of bias and estimated true IQ, both 
in the full sample (S1) (25). Dots = participants. Black line = linear regression line. Grey line 
= perfect agreement. Grey shadow = 95%-CI. r = Spearman’s correlation. *** = P < 0.001.
Figure 3: A) Correlation between F-IQ and S-IQ and B) F-IQ and corrected IQ in the 
subsample S1b. Dots = participants. Black line = linear regression line. Grey line = perfect 
agreement. Grey shadow = 95%-CI. r = Spearman’s correlation. *** = P < 0.001.
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Content summary: 
 This study investigates the agreement between IQ scores of short form and full length 
assessments in patients at risk for neurodevelopmental disorders
 A bias was found between full length IQs and estimated short-form IQs at the tails of 
the distribution
 A correction formula was provided to improve the agreement between short form and 
full length IQ scores 
 This is of particular interest when short form IQ scores are assessed in populations with 
an increased proportion of individuals with low IQ scores. 



































































Background: Short forms of IQ (S-IQ) assessments are time-efficient and highly predictive of 
the full IQ (F-IQ) in healthy individuals. To investigate the validity of S-IQs for patients with 
neurodevelopmental impairments, this study validated tested a well-established S-IQ version 
in patients with congenital heart disease (CHD). 
Methods: The Wechsler Intelligence Scale for Children, Fourth Edition was applied in 107 
children with complex CHD aged 9 to 11 years. F-IQ and a well-established S-IQ version were 
calculated for each patient. The agreement between S-IQ and F-IQ was investigated across the 
whole spectrum of IQ scores. Finally, we tested a method to adjust IQs to resolve potential bias 
and validated this method in an independent sample of 55 CHD patients. 
Results: S-IQ and F-IQ correlated strongly. Nevertheless, the size of the bias correlated with 
the true IQ, indicating larger error at the tails of the distribution. Estimating a corrected IQ by 
adjusting the S-IQ with correction parameters substantially improved agreement. 
Conclusion: We here report that substantial bias may underestimate low IQ scores and 
overestimate of high ones. This bias should be considered when at-risk populations are assessed 
with S-IQs. Importantly, the bias can be minimized by using a correction formula.



































































Many neurodevelopmental disorders are characterized by deficits in general intellectual 
abilities, reflected in lower intelligence quotients (IQs) than those of typically developing 
peers. For example, the mean IQ of preterm cohorts has been reported to lie about 10 IQ points 
below that of typically developing children (see Allotey et al. (1) for a meta-analysis). Children 
with congenital heart disease (CHD) after cardiopulmonary bypass (CPB) surgery have 
comparable IQ deficits (2–4). Low IQ scores, particularly those below internationally 
recognized cut-offs defining learning and intellectual disability, are associated with a higher 
need for therapeutic interventions and educational action (5,6). Consequently, IQ assessments 
in children at risk for neurodevelopmental disorders can guide long-term care and ensure the 
timely initiation of support (7,8).
In research settings, IQ assessment often complements the assessment of other 
neurodevelopmental domains, such as executive functions (9). A common practice in such 
settings is to administer only a subset of the tests used for full-scale IQ (F-IQ) assessment to 
avoid lengthy protocols, because these may reduce performance due to fatigue or loss of 
motivation in patients (10,11). Regression equation models have been developed to estimate 
IQ from various subsets of tests (11,12). These short IQ (S-IQ) assessments have been proven 
to accurately predict the F-IQ in large samples of typically developing children and adolescents 
(10,11) and in patients with neurological disorders (13). Moreover, most children with 
intellectual disabilities were identified correctly when S-IQ assessments were applied (14). 
Importantly, the administration of S-IQ assessments has been shown to reduce testing time by 
more than 50% compared to the administration of the full test (15).
So far, research on the appropriateness of S-IQ assessments in neurodevelopmental disorders 
has been limited. Several studies have tested various S-IQ versions in patients at risk for 
neurodevelopmental deficits, and their findings can guide the optimal selection of subtests for 


































































specific clinical populations (16–18). However, these studies have not examined whether S-IQ 
versions accurately measure IQ across the whole spectrum of IQ scores. In fact, there is 
evidence for a large bias in S-IQ scores outside the normal IQ range in healthy adults (19). This 
bias may be particularly pronounced in neurodevelopmental disorders due to the distribution 
shift towards lower IQ scores (7).
Consequently, this study aimed to comprehensively investigate the appropriateness of S-IQ 
assessment in a group of patients at risk for neurodevelopmental disorders, CHD patients. 
Specifically, we tested whether S-IQ assessments adequately estimate IQ across the whole 
spectrum of scores when IQ was assessed with the Wechsler Intelligence Scale for Children 4th 
Edition (WISC-IV). Further, we present a statistical approach to minimizing potential bias 
between S-IQ and F-IQ and validated this in an independent cohort of CHD patients.




































































Patients were recruited from the Research and Child Health Outcome (REACHOUT) cohort, 
which consists of 211 children who underwent CPB surgery at the University Children’s 
Hospital Zurich, Switzerland between 2004 and 2009. This prospective cohort study included 
6 5 assessments: Before surgery and at 1, 4, 6, and 10 years of age. The current study uses the 
data from the 10-year neurodevelopmental assessment (see Figure 1). Patients with a genetic 
or dysmorphic syndrome, CPB before study enrolment, or age above 6 years at first surgery 
were excluded from the 10-year assessment. Of 190 eligible patients, 136 agreed to participate. 
Twenty-eight patients did not complete all subtests of the WISC-IV required to calculate the 
S-IQ used in this validation study and were therefore excluded. In total, data of 107 patients 
was analyzed for the current validation study. To enable correction parameters to be developed, 
the total sample (S1) was divided into 2 subsamples (S1b, S1a) by random sampling.
The reproducibility of our findings was confirmed in an independent sample of patients with 
CHD (S2): We used the IQ data of 55 patients with CHD from a retrospective cohort study on 
CHD conducted at the University Children’s Hospital Zurich. These participants underwent 
CPB between 1995 and 1998 and were aged 11 to 16 years at the time of the study (for further 
details see Schaefer et al. (4)). 
The Ethical Committee of the Canton of Zurich, Switzerland approved both cohort studies. 
Written informed consent was obtained prior to the study participation from parents and from 
participants older than 11 years.
2.2. Outcome measures 
IQ was assessed by well-trained professionals using the full-length German version of the 
WISC-IV (20). Information on the heart defect was collected from medical records. Socio-


































































economic status (SES) was estimated by rating maternal education and paternal occupation on 
a 6-point scale ranging from 2 to 12 (21).
F-IQ was calculated according to the instructions provided in the manual of the WISC-IV and 
adjusted for age. The S-IQ was estimated according to a regression equation method described 
by Waldmann (11). We selected a subtest combination that retains the conceptual structure of 
the WISC-IV to preserve construct validity. This includes one subtest from each of the 4 
indices: working memory, processing speed, reasoning, and verbal comprehension. One-per-
index-subtest combinations are often used in research to estimate IQ (22–24). Of these subtest 
combinations, we chose the equation with the highest reliability according to Waldmann (11) 
(R2 = 0.911; subtests: letter–number sequencing, symbol search, matrices, vocabulary). 
2.3. Statistical analyses 
Sample characteristics—sex, age, SES, and type of heart defect (cyanotic, acyanotic)—are 
reported for both the full sample (S1) and the 2 subsamples (S1a, S1b) and the validation sample 
(S2). Two-sided Welch’s t-test allowing for unequal variance and a two-sampled chi-squared 
test were used to investigate the comparability of the 2 subsamples (S1a and S1b) and the full 
(S1) and validation samples (S2). 
2.3.1. Correlation and agreement between S-IQ and F-IQ 
The correlation between the F-IQ and the S-IQ was examined using Spearman’s correlation. 
We conducted 2 types of analyses to investigate the agreement between the F-IQ score and the 
S-IQ. First, we examined the overall agreement: We tested for a significant mean difference 
between the S-IQ and the F-IQ (i.e. the mean bias) by using a paired two-sided t-test. Further, 
the proportion of participants with a bias ≤ 5 IQ-points (within 95% CI) was calculated. Second, 
we analyzed whether the bias between the two IQ measurements (F-IQ, S-IQ) depends on the 


































































IQ itself (i.e., whether the bias is equal across the whole IQ spectrum). Thus, we correlated the 
bias with the estimated true IQ using Spearman’s correlation (25). The bias was defined as the 
absolute difference between the F-IQ and the S-IQ, and the true IQ was estimated from the 
mean of the S-IQ and F-IQ because using either value separately would cause a statistical 
artifact (26).
Agreement was further tested by dichotomizing the data above a clinically relevant cut-off into 
normal (IQ ≥ 85) or below into abnormal IQ (IQ < 85). In order to test for agreement, a two-
sampled chi-squared test was conducted using IQ type (F-IQ, S-IQ) as predictor and IQ score 
(normal, abnormal) as outcome. Further, the proportion of patients who fell into the same 
category for the S-IQ and the F-IQ was calculated.
2.3.2.Correction method for S-IQ. 
To minimize the bias between the F-IQ and the S-IQ, we applied a statistical method to estimate 
a corrected IQ. Therefore, the full sample (S1) was split into 2 subsamples by means of random 
sampling (S1b, S1a). We calculated a linear regression model for the subsample S1a, using S-IQ 
as predictor and F-IQ as outcome (F-IQ = β0 + β1* S-IQ). The intercept (β0) and slope (β1) were 
then used in the correction model to predict the corrected IQ of the subsample S1b: 
Corrected IQ1b = β01a + β11a * S-IQ1b
Two measures for quantifying the agreement with the F-IQ were calculated: the root mean 
square error (RMSE) and the mean absolute error (MAE). These were calculated for both the 
S-IQ and the corrected IQ and were then compared. A lower RMSE and MAE in the corrected 
IQ than in the S-IQ was interpreted as improvement of agreement.


































































2.3.3. Validation of the correction method.
Finally, we validated the correction method in another independent sample of CHD patients. 
We estimated a corrected IQ in the validation sample (S2) by implementing our correction 
parameters obtained from the subsample S1a (β0, β1) to the S-IQ of the validation sample (S2). 
All the statistical analyses were performed using the R computing environment, version 3.5.3 
(27,28). All analyses were performed with an α-level of 0.05. 




































































Table 1 provides sample characteristics of the full sample (S1), the 2 subsamples (S1a, S1b), and 
the validation sample (S2). Evidence for differences between the full and validation samples 
were found for age (t(55.7) = 16.60, P < 0.001, CI-95: from 3.03 to 3.86), and sex (χ 2(1) = 
6.21, P = 0.01). There was no difference for the type of heart defect (cyanotic and acyanotic; 
χ 2(1) = 1.64, P = 0.2) and only weak evidence for a difference in SES (t(92.9) = 1.88, P = 
0.06, CI-95: from -0.04 to 1.47). The 2 subsamples (S1a, S1b) did not differ in patient 
characteristics (see Table 1).
Table 2 provides F-IQ, S-IQ, and the mean difference between the F-IQ and the S-IQ (i.e., 
bias) for the full sample, the 2 subsamples and the validation sample. There was strong 
evidence of a difference in the mean F-IQ between the full sample S1 and the validation sample 
S2 (t(90.6) = 3.09, P = 0.003, CI-95: from 2.88 to 13.23). There was no evidence of a difference 
in mean F-IQ between the 2 subsamples (S1a, S1b: t(104.0) = 0.22, P = 0.8, CI-95: from -4.60 
to 5.76).
3.2. Correlation and agreement between S-IQ and F-IQ 
The analysis revealed a very strong correlation between the S-IQ and the F-IQ in the full sample 
(S1: r = 0.95, P < 0.001, Figure 2A). A two-sided paired t-test provided no evidence of a 
difference between S-IQ and F-IQ (S1: t(106) = 1.50, P = 0.1, CI-95: from -0.28 to 2.04). The 
mean difference between S-IQ and F-IQ (i.e., mean bias) in the full sample was 0.9 IQ point 
(Table 2). Furthermore, 81% of all participants had a bias ≤ 5 IQ points.
When considering IQ scores across the whole IQ spectrum, our findings revealed a very strong 
correlation between bias and the true IQ score (S1: r = -0.62, P < 0.001). A Bland-Altman plot 
of difference (Figure 2B) illustrates the underestimation of S-IQ for true IQ scores below the 


































































mean and the overestimation of S-IQ for true IQ scores above the mean. Correction parameters 
(for all one-per-index-subtest combinations with an r > 0.9, (11)) are listed in the Supplemental 
Table S1a and Figure S1b.
Categorizing S-IQ and F-IQ scores as normal (IQ ≥ 85) or abnormal (IQ < 85) revealed no 
evidence for a difference in the distribution between the categories in the full sample (S1: χ 2(1) 
= 0.65, P = 0.4). The proportion of patients of the full sample (S1) who fell into the same 
category for the S-IQ and the F-IQ was 93%.
3.3. Correction method for S-IQ 
The correction of the S-IQ of subsample S1b with the parameters (β0, β1) from the subsample 
S1a resulted in a mean corrected IQ of 95.7 (SD = 12.2, Table 2). The correlation between the 
F-IQ and the corrected IQ remained strong (r = 0.94, P < 0.001, Figure 3B; for comparison: 
correlation between F-IQ and uncorrected S-IQ: Figure 3A). Both RMSE (RMSES-IQ = 6.0; 
RMSEcorrected IQ = 4.1) and MAE (MAES-IQ = 4.5; MAEcorrected IQ = 3.3) were lower in the 
corrected IQ than in the S-IQ. This is evidence for successful correction of the bias using the 
correction formula provided in this study. 
To test the stability of the correction method, correction parameters (β0, β1) were also extracted 
from subsample S1b and applied to subsample S1a. The results were identical (see Supplemental 
Figure S2 S1 for details). Correction parameters (for all one-per-index-subtest combinations 
with an r > 0.9, (11))  and for further combinations consisting of 2 to 6 subtests … are listed in 
the Supplemental Table S21a and Figure S21b.
3.3.1. Validation of the correction method


































































The correction method was applied in a validation sample (S2) to further confirm its stability. 
Adjusting the S-IQ of the validation sample (S2) with the correction parameters (β0, β1) from 
the subsample (S1a) resulted in a mean corrected IQ of 104.9 (SD = 15.9, Table 2). The 
correlation between the F-IQ and the corrected IQ remained strong (r = 0.93, P < 0.001, 
Supplemental Figure S3). Both RMSEs (RMSES-IQ = 7.8; RMSEcorrected IQ = 4.6) and MAE 
(MAES-IQ = 6.3; MAEcorrected IQ = 3.4) were lower in the corrected IQ than in the S-IQ. This is 
evidence for successful correction of the bias in the validation sample.



































































In this validation study, we investigated whether short forms of IQ assessments (S-IQ) 
accurately estimate IQ scores in patients at risk for neurodevelopmental disorders. Our results 
indicate that while the correlation between the full-length IQ assessment (F-IQ) and S-IQ is 
high overall, IQ scores at the tails of the distribution are not accurately measured when using 
S-IQ assessments. Using our correction method, we were able to considerably reduce this bias.
In this analysis of children and adolescents with CHD, a population with frequent 
neurodevelopmental impairments, we calculated F-IQ scores from the full WISC-IV and S-IQ 
scores from a well-established 4-subtest version (11). First, we demonstrated a strong 
correlation between the S-IQ and the F-IQ scores. These findings are in line with previous 
studies on both healthy participants (10,11) and patients with neurological disorders (13,17). 
On examining the agreement between these two IQ measures, we observed a substantial 
variation in bias across the spectrum of IQ: S-IQ scores were underestimated in the lower 
spectrum of IQ and overestimated in the higher spectrum. This bias was replicated in various 
other subtest combinations (see Supplemental Table S2a and Figure S2b) and in an independent 
sample of CHD patients. A previous study in healthy adults that used other estimates of the 
Wechsler adult intelligence scale, 3rd edition, also reported larger bias at the tails of the 
distribution (19).
Time-efficient assessments of IQ by means of S-IQ methods are particularly valuable in 
research settings because IQ is often not the primary outcome of interest but serves merely as 
a covariate or patient characteristic to allow inferences to be drawn about potential selection 
bias and generalizability from the assessed cohort (29). Using short forms allows more time 
for the detailed assessment of developmental domains of interest, such as executive function 
(4,9) and memory performance (30). However, the usefulness of S-IQs has long been a matter 
of debate (31,32). In particular, concerns have been raised whether the construct validity 


































































assessed in a sample with a full-length assessment holds true when only a subsample of tests 
is applied (11,32). For this reason, we aimed to retain the best construct validity possible by 
using a one-subtest-per-index short form. This approach has frequently been used in previous 
studies (e.g. (22–24)). Furthermore, it has been debated whether S-IQ scores are valid in 
samples whose IQ distributions differ from those of the general population, for example in 
patients with population-specific cognitive deficits. Indeed, several studies have reported 
considerable mean IQ differences between S-IQ and F-IQ versions in cohorts of patients with 
epilepsy (17), traumatic brain injury (16), neurologic disorders (13), and borderline intellectual 
disabilities (18). However, these studies only investigated overall mean differences between 
the S-IQ and the F-IQ, not the changing size and direction of bias across the whole spectrum 
of IQ scores. Our finding that bias is largely restricted to the tails of the distribution suggests 
that the significant mean differences observed in those studies likely occurred due to large 
biases in low IQ scores. 
Importantly, the bias observed between the mean S-IQs and F-IQs of a population only 
provides very limited information on the agreement between the 2 measures because it does 
not reflect the spectrum of scores. The concept of agreement has been discussed extensively in 
the past. Unfortunately, there is confusion about appropriate concepts to test the agreement 
between 2 measurements, and this can lead to misinterpretation of results (33). Appropriate 
methods to investigate agreement consider the degree of bias across the whole spectrum of 
scores and therefore provide substantial information about the quality of a measurement (25). 
Therefore, this validation study examined bias across a whole spectrum of IQ scores by 
correlating the bias with the estimated true IQ, as suggested by Altman and Bland (25).
The fact that the bias occurs predominantly at the tails of the distribution may reflect a 
statistical phenomenon, called regression to the mean, which causes one measurement to be 
closer to the population mean than another measurement of the same entity. This is especially 


































































apparent for values outside the normal range (34). Regression to the mean has previously been 
discussed as a problem affecting the interpretation of IQ scores (35–37). In particular, F-IQ 
scores outside the normal range tend to be closer to the mean than the corresponding S-IQ 
scores, since sporadic extreme subtest scores are weighted less in the F-IQ. Our findings show 
that it is particularly important to consider the distribution of the data when S-IQ scores of 
populations at risk for neurodevelopmental impairments are used in statistical analyses. 
To overcome the bias between F-IQ and S-IQ measures, we tested a correction method to 
resolve this problem. Correction parameters were obtained from one subsample and were 
applied to the other subsample to estimate a corrected IQ. We observed an improved agreement 
between the 2 measurements: The RMSE of the S-IQ was as high as 6 before the correction, 
indicating low agreement (11). The RMSE of the corrected IQ was substantially reduced 
(RMSE = 4.1), reflecting a considerable improvement in agreement. These findings underline 
that correcting S-IQ scores may well improve the validity of an estimate, especially when its 
distribution differs from the normative sample.
The correction formula proved useful both when subdividing the full sample into 2 random 
subsamples and when correcting the S-IQ of an independent validation sample of CHD patients 
(S2). Indeed, very similar improvements of IQ estimations were found in the validation sample 
(S2) that was different in regard to age, SES, and sex. The mean F-IQ of the validation sample 
and its distribution differed strongly from the original full sample (S1). In fact, the mean IQ of 
the validation sample was above average, and its distribution was left-skewed, in all likelihood 
due to selection bias (4). Nevertheless, the correction formula also worked in this very different 
sample of patients with CHD. This implies that the correction formula we present here may 
also reduce bias in other samples with abnormal distributions of IQ, irrespective of the direction 
of the skewness. This may be of particular interest for the correction of bias in typically 


































































developing control groups, as sampling bias is a well-known problem with high-functioning 
individuals (38). 
If IQ estimates serve to describe the proportion of individuals with clinically relevant IQ 
deficits, S-IQ scores may be categorized into normal (IQ ≥ 85) and abnormal IQ (IQ < 85). Our 
findings reveal that a high proportion of participants were categorized correctly with the S-IQ. 
These findings are in line with a study by Murray and colleagues (14), who used a cut-off score 
of 70 and successfully identified children with intellectual disabilities using an S-IQ estimation. 
This method is easy to apply when concerns about bias are present. However, categorizing data 
results in a loss of valuable information (39). Therefore, it is important to consider why the IQ 
has been measured and decide whether using categories only is appropriate. 
Taken together, using S-IQs and the presented correction formula may be useful in research 
settings to provide an appropriate estimation of general intellectual abilities, especially when 
IQ serves as a secondary outcome. In clinical settings, the full length assessment of IQ is, 
however, preferable as only this provides a detailed assessment of the global IQ and the 
respective indices. This is required to identify deficits in specific cognitive domains and to 
initiate appropriate interventions.
4.1. Limitations
Our validation study has several limitations worth mentioning. We investigated a cohort of 
patients with CHD as one example of populations at risk for neurodevelopmental impairments. 
Therefore, our findings cannot directly be transferred to other at-risk populations. Other studies 
should investigate clinical populations with a higher proportion of individuals with very low 
IQ (e.g. severe intellectual disabilities) in order to confirm the validity of the correction 
formula. Also, future studies should validate our findings in populations with different profiles 
of cognitive impairment may differ widely between patient populations (17). 


































































However,Nevertheless, the cognitive profile of children born very preterm is akin to that of 
patients with CHD (40), so we propose that the correction formula presented here could also 
be applied to correct the S-IQ scores of preterm-born children.
We did not have a control sample assessed with the full WISC-IV. Therefore, we could not 
compare the correlation and agreement of F-IQ with S-IQG between typically developing 
children and adolescents and those with CHD. However, a study by Spinks and colleagues (19) 
in healthy adults has also reported a higher proportion of large bias (> 5 IQ points) at the tails 
of the distribution than within the normal range. This finding indicates that the bias in the outer 
spectrum may also occur in cohorts of healthy individuals. The proportion of individuals with 
IQ scores below 85 is rather low in typically developing cohorts, though, so this may have less 
bearing than in at-risk populations. 
This validation study only investigated estimates of IQ by means of equation models but did 
not consider other methods (e.g. Wechsler abbreviated scale for intelligence 2nd Edition 
(WASI-II), Wechsler 19992011). This was mainly because the equation models published by 
Waldmann (11) are frequently used in research on German-speaking populations with various 
clinical characteristics (e.g. (22–24)). Further, we only investigated a variety of 4-subtest 
versions designed to minimize testing time while retaining the conceptual structure of the 
WISC-IV. Thus, we cannot draw any conclusion regarding the agreement and potential 
correction methods in S-IQ obtained from other estimates. 
Our analyses on S-IQ were done with data of patients who conducted the full length WISC-IV 
assessment. Applying a short form version requires considerably less time (15), which may 
lead to less fatigue and better motivation (13), resulting in a better outcome. This has to be 
considered when short forms and the presented correction formula are used. However, the short 
form estimates by Waldmann (11) were also developed from data of the full length assessment. 
Our analyses are, therefore, in line with the original work of Waldmann.



































































S-IQs measured in a sample of children with CHD with a well-established 4-subtest version 
revealed a lack of agreement with F-IQs at the tails of the distribution, namely in low and high 
performers of the WISC-IV, especially in scores outside the normal range. This warrants 
particular consideration when investigating populations whose IQ scores differ from those of 
the general population. Bias between S-IQ and F-IQ scores can be diminished either by 
dichotomizing the data into scores above or below 85 or by using a correction formula 
presented in this study.
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Figure Legends 
Figure 1: Flow diagram of participant selection for sample S1. y FU = year follow up
Figure 2: A) Correlation of S-IQ and F-IQ. B) Correlation of bias and estimated true IQ, both 
in the full sample (S1) (25). Dots = participants. Black line = linear regression line. Grey line 
= perfect agreement. Grey shadow = 95%-CI. r = Spearman’s correlation. *** = P < 0.001.
Figure 3: A) Correlation between F-IQ and S-IQ and B) F-IQ and corrected IQ in the 
subsample S1b. Dots = participants. Black line = linear regression line. Grey line = perfect 
agreement. Grey shadow = 95%-CI. r = Spearman’s correlation. *** = P < 0.001.


































































Table 1: Sample characteristics of the full sample (S1), its subsamples (S1a, S1b), and the 
validation sample (S2)












Age (Mean, range) 10.2 (9-11) 10.2 (9-11) 10.3 (9-11) 13.7(11-16) < 0.001 0.8
Sex (%, female) 35% 32% 37% 56% 0.01 0.7
SES (Mean, range) 8.5 (4-12) 8.5 (4 – 12) 8.5 (4 – 12) 7.8(3-12) 0.06 0.9
Cyanotic CHD (%) 36% 31% 40% 47% 0.2 0.5


































































Table 2: Comparison of F-IQ and S-IQ for all samples and comparison of F-IQ and corrected 
IQ for the subsample (S1b) and the validation sample (S2).
Mean Standard deviation Range Mean Difference a
Full sample (S1)
F-IQ 95.7 13.4 53 – 120
S-IQ 94.8 17.2 49.2 – 126.0 - 0.9
Subsample (S1a)
F-IQ 95.3 14.0 53 – 120
S-IQ 94.6 18.1 49.2 – 123.2 - 0.7
Subsample (S1b)
F-IQ 95.9 12.9 61 – 118
S-IQ 95.0 16.4 53.3 – 126.0 - 0.9
Corrected IQ 95.7 12.2 64.8 – 118.6 - 0.2
Validation sample (S2)
F-IQ 103.7 16.7 44 - 131
S-IQ 107.5 21.5 25 - 142 -3.8
Corrected IQ 104.9 15.9 43.8 – 130.6 1.2
a Mean bias between S-IQ and F-IQ.



































































Figure 1: Flow diagram of participant selection for sample S1. y FU = year follow up 
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Figure 2: A) Correlation of S-IQ and F-IQ. B) Correlation of bias and estimated true IQ, both in the full 
sample (S1) (25). Dots = participants. Black line = linear regression line. Grey line = perfect agreement. 
Grey shadow = 95%-CI. r = Spearman’s correlation. *** = P < 0.001. 
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Figure 3: A) Correlation between F-IQ and S-IQ and B) F-IQ and corrected IQ in the subsample S1b. Dots = 
participants. Black line = linear regression line. Grey line = perfect agreement. Grey shadow = 95%-CI. r = 
Spearman’s correlation. *** = P < 0.001. 
203x101mm (600 x 600 DPI) 



































































203x101mm (600 x 600 DPI) 


































































Supplemental Table S21a: Correction formula for each one-per-index-subtest combination 




Correction formula for corrected IQ Scenarios according to 
Waldmann (11)
LNS-SS-M-V 25.366 + 0.740 * S-IQ One-per-index, Max. RSQ
1 BD-V-LNS-SS 27.205 +  0.728 * S-IQ One-per-index 
2 DS-V-M-SS 26.162 + 0.735 * S-IQ One-per-index
3 PC-V-LNS-SS 22.813 + 0.775 * S-IQ One-per-index
4 BD-C-V-LNS 29.027 + 0.709 * S-IQ One-per-index
5 S-LNS-M-SS 26.187 + 0.719 * S-IQ One-per-index
6 C-V-LNS-M 26.258 + 0.730 * S-IQ One-per-index
7 BD-S-C-LNS 28.988 + 0.697 * S-IQ One-per-index
8 BD-S-DS-C 26.445 + 0.727 * S-IQ Balance (M177)
9 BD-PC-V-LNS-
M-SS
26.971 + 0.720 * S-IQ Max. RSQ (M754)
10 PC-V-LNS-M-SS 24.243 + 0.750 * S-IQ Max. RSQ (M628)
11 V-M-SS 24.288 + 0.749 * S-IQ Max. RSQ (M 170)
12 BD-S 25.664 + 0.711 * S-IQ Sequence (M011)
BD=Block-design, C=Coding, DS= Digit-span, LNS=letter-number-sequencing, M=Matrices, 
PC=Picture-concepts, SS=symbol-search, S=Similarities, V=vocabulary
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Supplemental Figure S1b: Correlation between F-IQ and S-IQ, as well as F-IQ and corrected 
IQ in the subsample S1b. Correction parameters were obtained from subsample S1a. Numbers 
correspond to Supplemental Table S1a.  Dots = participants. Black line = linear regression line. 
Grey line = perfect agreement. Grey shadow = 95%-CI.
Supplemental Figure S2S1: A) Correlation between F-IQ and S-IQ and B) F-IQ and corrected 
IQ in the subsample n1a. Correction parameters were obtained from subsample n1bS1b. Dots = 
participants. Black line = linear regression line. Grey line = perfect agreement. Grey shadow = 
95%-CI. r = Spearman’s correlation. *** = P < 0.001.
Supplemental Figure S12b: Correlation between F-IQ and S-IQ, as well as F-IQ and corrected 
IQ in the subsample S1b. Correction parameters were obtained from subsample S1a. Numbers 
correspond to Supplemental Table S12a.  Dots = participants. Black line = linear regression line. 
Grey line = perfect agreement. Grey shadow = 95%-CI.
Supplemental Figure S3: A) Correlation between F-IQ and S-IQ and B) F-IQ and corrected 
IQ in the replication sample n2. Correction parameters were obtained from subsample n1b. Dots 
= participants. Black line = linear regression line. Grey line = perfect agreement. Grey shadow 
= 95%-CI. r = Spearman’s correlation. *** = P < 0.001.
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